International Cannabis Weekly: 312

GERMANY’S ‘MOST IMPORTANT’ CANNABIS REFORM SINCE 2017 CLEARS FIRST HURDLE

Germany has taken a significant step towards fulfilling its ambitious plans to roll out an adult-use cannabis framework this week, after the draft bill was approved by the Bundesregierung (Federal Cabinet).

READ MORE  »

SWITZERLAND’S FLOURISHING CANNABIS PILOTS GAIN EUROPEAN SPOTLIGHT

READ MORE »

OHIO COULD SEE $400 MILLION IN TAX REVENUE IF CANNABIS MEASURE APPROVED

READ MORE »

• Malta’s cannabis regulatory body issues its first two cannabis association licences, ‘in-principle’.
• NHS Scotland to fund six-figure clinical trial to explore the effects of CBD on pelvic pain related to endometriosis. 
• UK research finds GP support for cannabis as an alternative to opioids for chronic pain.
• Ireland’s cannabis legalisation debate continues to rumble on, with staunch supporters in both the pro and con camp.
• The Association for the Cannabinoid Industry (ACI) puts pressure on UK Home Office to set THC limit.
• German cannabis group SynBiotic SE sees its stock price jump by nearly 50% to levels not seen since April.

READ WEEKLY STOCK REPORT »

• US cannabis businesses braced for increasing threats from criminals following Mastercard’s ban on cannabis purchases.
• Poseidon Dynamic Cannabis ETF (Exchange Traded Fund) to shut down less than two years after launching.
• Draft summary of South Dakota’s cannabis legalisation initiative released by the attorney general.
• New York’s Columbia Care sees Q2 revenue increase, achieving 4% sequential growth.
• US researchers shed light on how HHC binds to receptors in the body – and propose a safer way to produce them.
• New research shows state medical cannabis programmes lower health insurance premiums.

PRE-ORDER NOW »

• Canada’s Halo Collective delists from CBOE Exchange after string of ‘challenging’ results.
• Aurora Cannabis reports skyrocketing revenues alongside falling losses in Q1 of the 2024 fiscal year.
• Federal judge orders Health Canada to review its Organigram case over what constitutes a cannabis edible.
• Avicanna Inc. gets Q2 revenue report boost following Medical Cannabis by Shoppers Drug Mart acquisition.
• Delta 9 reports Q2 results with company sales at C$18.25 million compared to C$17.5 million a year ago.
• Canopy Growth sees significant drop in short interest, a decrease of 9.8% from the 15 July total.

FIND OUT MORE »

• Brazil’s Supreme Federal Court (STF) resumes debate on the decriminalisation of cannabis for personal use.
• Argentina’s cannabis commerce set to take off as new categories open doors to huge domestic market.

• Anvisa, the Health Regulatory Agency in Brazil, forbids advertising and promotion of cannabis-derived products.

• How to obtain authorisation from the Brazilian Health Regulatory Agency to market cannabis-based medicines.

• Medcan doubles capacity with its new purpose-built indoor growing facility in Queensland.
• Australia makes history by introducing its first-ever bill into parliament to legalise cannabis for recreational use nationally.
• Breathe Life Sciences and CanXChange launch AI-powered B2B pharmaceuticals platform in Australia.
• Great Southern’s cannabis retreat receives overwhelming support as images of the development are released.

• Zimbabwe’s Second Republic lifts barriers for health professionals to study medicinal cannabis.
• South Africa’s Cilo Cybin Holdings granted approval to list on Johannesburg Stock Exchange (JSE).